Finally, we conducted a clinical analysis using the CGGA and TCGA datasets and our samples and discovered that CDC20 was overexpressed in high-grade gliomas versus low-grade gliomas and normal brain tissue. The gene discussed is CDC20; the disease is central nervous system cancer.